Země: Austrálie
Jazyk: angličtina
Zdroj: Department of Health (Therapeutic Goods Administration)
Squalene
RBK Nutraceuticals Pty Ltd
Squalene
Medicine Listed
QUESTRAN LITE _colestyramine_ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about QUESTRAN LITE. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you taking QUESTRAN LITE against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET. You may need to read it again. WHAT QUESTRAN LITE IS USED FOR QUESTRAN LITE is used: • to reduce high levels of cholesterol in the blood assist in the prevention of coronary heart disease. It also used as an accompanying therapy to you diet in order to reduce cholesterol • for the relief of pruritis (itching) associated with the flow of bile being partially blocked • for the relief of diarrhoea caused by surgery or disease of the small bowel This medicine belongs to a group of medicines called resins. It reduces the level of cholesterol in the blood by combining with bile in the small intestine to form an insoluble complex, which is then excreted in faeces. The reduction of blood cholesterol levels helps to prevent blockages in the blood vessels to the heart which reduces the likelihood of angina (chest pain with heart disease) and heart attacks. QUESTRAN LITE may be used alone or in combination with other medicines. ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY THIS MEDICINE HAS BEEN PRESCRIBED FOR YOU. Your doctor may have prescribed this medicine for another reason. This medicine is not addictive. This medicine is only available with a doctor’s prescription. The safety and effectiveness of using QUESTRAN LITE in infants and children has not been established. BEFORE YOU USE IT _WHEN YOU MUST NOT USE IT_ DO NOT USE QUESTRAN LITE IF YOU HAVE AN ALLERGY TO • any medicine containing colestyramine • any of the ingredients listed at the end of this leaflet Symptoms of an allergic rea Přečtěte si celý dokument
AUSTRALIAN PRODUCT INFORMATION QUESTRAN LITE _colestyramine powder for oral solution _ 1 NAME OF THE MEDICINE Colestyramine 2 QUALITATIVE AND QUANTITATIVE COMPOSITION QUESTRAN LITE is a powder for oral solution containing 850 mg per gram of colestyramine as the active ingredient. The 4.7 g sachet contains 4 g of colestyramine and the 9.4 g sachet contains 8 g of colestyramine. Excipients of known effect: aspartame For the full list of excipients, see section 6.1 List of Excipients. 3 PHARMACEUTICAL FORM QUESTRAN LITE is a cream coloured, fine, dispersible powder. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS 1. Reduction of serum cholesterol levels and prevention of coronary heart disease. QUESTRAN LITE is indicated as adjunctive therapy to diet for the reduction of elevated serum cholesterol in patients with primary hypercholesterolemia (elevated low-density lipoproteins). QUESTRAN LITE may be useful to lower elevated cholesterol that occurs in patients with combined hypercholesterolemia and hypertriglyceridemia, but it is not indicated where hypertriglyceridemia is the abnormality of most concern 2. Relief of pruritus associated with partial biliary obstruction. Patients with primary biliary cirrhosis may exhibit elevated serum cholesterol as part of their disease. When colestyramine is used to treat the pruritus of partial biliary obstruction, it may lower serum cholesterol levels, produce no change, or cause rapid escape from a temporary lowering to pre-treatment levels or rebound 3. Relief of diarrhoea following ileal resection or ileal disease (cholerrhoeic enteropathy) 4.2 DOSE AND METHOD OF ADMINISTRATION ADULTS Usual maintenance therapy: 12 to 16 g of colestyramine equivalent to 14.1 to 18.8 g QUESTRAN LITE per day (without regard to meals), is usually effective. CHILDREN Dosage in infants and children has not been established. Begin therapy with small doses. Subsequent adjustment should be made according to clinical response or laboratory results and the benefit/risk ratio. USE FOR CHOLESTEROL LOWE Přečtěte si celý dokument